Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01927120
What this trial is testing

In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis

Who this might be right for
Graft-Versus-Host-Disease
H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Study completedNCT01795573
What this trial is testing

Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT06026371
What this trial is testing

Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center 157
Testing effectiveness (Phase 2)Study completedNCT04503616
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

Who this might be right for
Graft-versus-host Disease
NYU Langone Health 46
Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30
Not applicableNot Yet RecruitingNCT06490562
What this trial is testing

Low-dose Cyclophosphamide or CNI in the Prevention of Acute Graft-versus-host Disease After gDLI

Who this might be right for
Acute Graft-versus-host Disease
Institute of Hematology & Blood Diseases Hospital, China 66
Large-scale testing (Phase 3)UnknownNCT02506231
What this trial is testing

The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome

Who this might be right for
Graft vs Host DiseaseAllogeneic Hematopoietic Cell TransplantationMucositis
Rabin Medical Center 160
Testing effectiveness (Phase 2)UnknownNCT03840512
What this trial is testing

An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)

Who this might be right for
Prevention aGVHD
Kalytera Therapeutics Israel, Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT01665677
What this trial is testing

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft vs Host Disease
Mehdi Hamadani 69
Testing effectiveness (Phase 2)Study completedNCT00186628
What this trial is testing

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Who this might be right for
Leukemia, Mast-CellMantle-cell Lymphoma
Stanford University 36
Large-scale testing (Phase 3)UnknownNCT02270307
What this trial is testing

MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis

Who this might be right for
LeukemiaMultiple Myeloma
National Research Center for Hematology, Russia 40
Testing effectiveness (Phase 2)Study completedNCT00785330
What this trial is testing

Allo-hNHL (FluBuCy)

Who this might be right for
Non-Hodgkin's Lymphoma
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 84